Weersink et al give recommendations for prescribing proton pump inhibitors (PPIs) in patients with cirrhosis. The authors are from multiple institutions in The Netherlands.
Therapy with a PPI in a cirrhotic:
(1) may be associated with infections (spontaneous bacterial peritonitis, others)
(2) may precipitate hepatic encephalopathy
(3) may be continued for no clear indication
Proton pump inhibitors are metabolized in the liver (CYP2C19, CYP3A4). End-stage liver disease can result in accumulation of some PPIs.
PPI's for Child-Pugh-Turcotte (CTP) grade A and B, with reduction in maximum dose:
PPI for CTP grade C:
(1) esomeprazole, with maximum dose 20 mg per day
PPIs to avoid:
To read more or access our algorithms and calculators, please log in or register.
Specialty: Pharmacology, clinical, Gastroenterology